188 related articles for article (PubMed ID: 33246537)
1. Imaging of Head and Neck Cancer With CT, MRI, and US.
Junn JC; Soderlund KA; Glastonbury CM
Semin Nucl Med; 2021 Jan; 51(1):3-12. PubMed ID: 33246537
[TBL] [Abstract][Full Text] [Related]
2. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
3. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of simultaneous whole-body
Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
[TBL] [Abstract][Full Text] [Related]
7. PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system.
Sekine T; de Galiza Barbosa F; Kuhn FP; Burger IA; Stolzmann P; Huber GF; Kollias SS; von Schulthess GK; Veit-Haibach P; Huellner MW
Clin Imaging; 2017; 42():232-239. PubMed ID: 28129606
[TBL] [Abstract][Full Text] [Related]
8. Utility of imaging techniques in the diagnosis of oral cancer.
Sarrión Pérez MG; Bagán JV; Jiménez Y; Margaix M; Marzal C
J Craniomaxillofac Surg; 2015 Nov; 43(9):1880-94. PubMed ID: 26325616
[TBL] [Abstract][Full Text] [Related]
9. [Role and responsibility of multimodal imaging in head and neck cancer].
Gõdény M
Magy Onkol; 2013 Sep; 57(3):182-202. PubMed ID: 24107825
[TBL] [Abstract][Full Text] [Related]
10. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
11. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
12. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
Ng SP; Bahig H; Wang J; Cardenas CE; Lucci A; Hall CS; Meas S; Sarli VN; Yuan Y; Urbauer DL; Ding Y; Ikner S; Dinh V; Elgohari BA; Johnson JM; Skinner HD; Gunn GB; Garden AS; Phan J; Rosenthal DI; Morrison WH; Frank SJ; Hutcheson KA; Mohamed ASR; Lai SY; Ferrarotto R; MacManus MP; Fuller CD
BMC Cancer; 2018 Sep; 18(1):903. PubMed ID: 30231854
[TBL] [Abstract][Full Text] [Related]
13. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
14. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer.
Hwang HS; Perez DA; Orloff LA
Laryngoscope; 2009 Oct; 119(10):1958-65. PubMed ID: 19688854
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.
Gregor RT; Valdés-Olmos R; Koops W; Balm AJ; Hilgers FJ; Hoefnagel CA
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):509-14. PubMed ID: 8615968
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
[TBL] [Abstract][Full Text] [Related]
17. PET/MRI vs PET/CT in Head and Neck Imaging: When, Why, and How?
Ryan JL; Aaron VD; Sims JB
Semin Ultrasound CT MR; 2019 Oct; 40(5):376-390. PubMed ID: 31635765
[TBL] [Abstract][Full Text] [Related]
18. PET/MR in Head and Neck Cancer - An Update.
Huellner MW
Semin Nucl Med; 2021 Jan; 51(1):26-38. PubMed ID: 33246536
[TBL] [Abstract][Full Text] [Related]
19. PET/CT and PET/MR Imaging of the Post-treatment Head and Neck: Traps and Tips.
Guzmán Pérez-Carrillo GJ; Ivanidze J
Neuroimaging Clin N Am; 2022 Feb; 32(1):111-132. PubMed ID: 34809833
[TBL] [Abstract][Full Text] [Related]
20. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
